T37.2X2 Poisoning by antimalarials and drugs acting on other blood protozoa, intentional self-harm

Name of the Condition

• Poisoning by antimalarials and drugs acting on other blood protozoa, intentional self-harm

Summary

This condition involves intentional self-harm through poisoning by antimalarial medications or drugs targeting other blood protozoa. It includes deliberate ingestion or exposure to these agents with the intent to cause harm, which may result in toxic effects, adverse reactions, or overdose. The clinical presentation depends on the specific drug, dose, and patient factors.

Causes

Intentional self-harm poisoning can result from deliberate overdose, misuse, or intentional exposure to antimalarial or blood protozoa drugs. This may occur due to suicidal ideation, attempts to self-medicate, or other intentional acts involving these medications.

Risk Factors

• History of mental health conditions (e.g., depression, anxiety) increasing self-harm risk.
• Access to antimalarial or blood protozoa medications.
• Prior episodes of intentional self-harm or suicidal behavior.
• Social or environmental stressors contributing to self-harm tendencies.

Symptoms

• Gastrointestinal: Nausea, vomiting, abdominal pain, or diarrhea.
• Neurological: Dizziness, confusion, seizures, or altered mental status.
• Cardiovascular: Irregular heartbeat, hypotension, or cardiac arrhythmias.
• Dermatological: Rash, itching, or hypersensitivity reactions.
• Metabolic: Electrolyte imbalances or acid-base disturbances.
• Respiratory: Shortness of breath or respiratory depression (in severe cases).

Diagnosis

Clinical evaluation focuses on medication history, symptom onset, and lab tests (e.g., drug levels, renal/hepatic function). A thorough psychosocial assessment is critical to determine intent and guide management. Imaging or other tests may be used to assess organ damage or complications.

Treatment Options

Treatment involves immediate medical stabilization, including airway management, supportive care, and specific antidotes if available. Psychiatric evaluation and intervention are essential. Long-term care may include therapy, medication management, and safety planning to prevent recurrence.

Prognosis and Follow-Up

Prognosis depends on the drug involved, dose, and timeliness of treatment. Early intervention improves outcomes. Follow-up includes monitoring for physical complications and ongoing mental health support. Regular assessments help address underlying risk factors and reduce future self-harm risk.

Complications

• Organ damage (e.g., hepatic, renal, or cardiac) from toxicity.
• Neurological sequelae (e.g., seizures, cognitive impairment).
• Electrolyte imbalances or metabolic disturbances.
• Psychiatric complications, including recurrent self-harm or suicidal behavior.

Lifestyle & Prevention

• Secure storage of medications to limit access.
• Education on safe medication use and disposal.
• Mental health support and crisis intervention resources.
• Regular follow-up with healthcare providers for at-risk individuals.

When to Seek Professional Help

Seek immediate medical attention for suspected poisoning, especially with intentional self-harm. Contact emergency services or a healthcare provider if symptoms like severe nausea, confusion, seizures, or altered consciousness occur. Prompt evaluation is critical for safety and treatment.

Tips for Medical Coders

Document the intent (intentional self-harm) clearly in the medical record. Include details on the specific antimalarial or blood protozoa drug involved, dose, and clinical findings. Ensure the code T37.2X2 is used when the poisoning is confirmed as intentional self-harm. Follow facility guidelines for coding and documentation accuracy.